Autopsy report · NCT01839552

An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.

“Site chose to close due to lack of enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of Louisville

Sponsor type

University, hospital or other

Conditions

Pain

Interventions

Fentanyl Citrate Nasal Spray (FCNS)

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
  “Closed by sponsor, lack of enrollment.” (76% match in meaning)
• Pilot Study of Human Tear Proteins
  “Stopped due to low enrollment” (75% match in meaning)
• A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
  “Closed due to slow enrollment” (75% match in meaning)
• The Metabolomics of Anaphylaxis
  “We are closing the study because of lack of enrollment.” (74% match in meaning)
• Study to Determine the Effect of Azasite on Corneal Surface Irregularity
  “Lack of enrollment” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.